Reversible cerebellar ataxia related to extrapontine myelinolysis without hyponatremia after cisplatin-based chemotherapy for cholangiocarcinoma

5Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

A 60-year-old woman presented with cerebellar signs including dysarthria and ataxia, after intravenous infusion of cisplatin-based chemotherapy. Several blood tests showed mild neutropenia, normocytic normochromic anemia, but no evidence of a marked hyponatremia. Brain magnetic resonance imaging with diffusion-weighted sequences showed hyper-intense signal abnormalities in the extrapontine region, sparing the basis pontis. Here, we report on the case of a patient with reversible cerebellar ataxia related to extrapontine myelinolysis without hyponatremia after treatment with cisplatin-based chemotherapy for cholangiocarcinoma and discuss the literature on cerebellar ataxia in patients who underwent recent chemotherapy for malignancy.

Cite

CITATION STYLE

APA

Chung, J. H., Baik, S. K., Cho, S. H., & Kim, S. G. (2015). Reversible cerebellar ataxia related to extrapontine myelinolysis without hyponatremia after cisplatin-based chemotherapy for cholangiocarcinoma. Cancer Research and Treatment, 47(2), 329–333. https://doi.org/10.4143/crt.2013.145

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free